Up-to-date news about Intravacc
Stay informed about the latest developments in our mission to pioneer transformative vaccines with up-to-date corporate communications. Get the latest news on our development and business milestones, as well as industry insights, partnership announcements, and corporate reports.
Enabling Tech Transfer of B. pertussis OMV Technology to our Partner Chonquing Zhifei Biological Products
CEPI partners with Intravacc to develop an intranasal, broadly protective Betacoronavirus vaccinee
Intravacc signs an exclusive license agreement with Zhifei Lvzhu Biopharmaceutical to commercialize Avacc 3
Intravacc announces the publication of a GMP process for a semi-synthetic Shigella glycoconjugate vaccine candidate from the Institut Pasteur
Intravacc and Therapyx jointly develop the world's first prophylactic gonorrhea vaccine
